首页> 外文期刊>Transactions of the Royal Society of Tropical Medicine and Hygiene >Risk factors for malaria in pregnancy in an urban and peri-urban population in western Kenya.
【24h】

Risk factors for malaria in pregnancy in an urban and peri-urban population in western Kenya.

机译:肯尼亚西部城市和城市郊区人口中妊娠疟疾的危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

To assess risk factors for malaria in pregnancy in Kisumu, western Kenya, we studied healthy women with an uncomplicated pregnancy of > or = 32 weeks attending the antenatal clinic in the Provincial Hospital. Between June 1996 and March 1999, malaria and human immunodeficiency virus (HIV) infection were examined in 5093 pregnant women: 20.1% of the women were parasitaemic and 24.9% were HIV-seropositive. 2502 women delivered in the hospital and a smear was obtained: the prevalence of placental malaria, maternal peripheral parasitaemia, and HIV infection was respectively 19.0%, 15.2% and 24.5%. HIV infection (risk ratio [RR] 1.58, 95% confidence interval [95% CI] 1.32-1.89), young age (< 21 years: RR 1.51, 95% CI 1.19-1.91), being a primigravidae (RR 1.41, 95% CI 1.05-1.88), a peri-urban residence (RR 1.50, 95% CI 1.21-1.88), and Luo ethnicity (RR 1.74, 95% CI 1.35-2.24) were risk factors for malaria at delivery. Use of sulfadoxine-pyrimethamine (SP), reported by 2.1% of the women, was a protective factor (RR 0.44, 95% CI 0.18-1.06). Results were similar in the third trimester. In this urban/peri-urban setting, preventing HIV infection, delaying the first pregnancy until after adolescence, and applying an effective antimalarial strategy such as intermittent therapy with SP will reduce the prevalence of malaria in pregnancy.
机译:为了评估肯尼亚西部基苏木市怀孕中疟疾的危险因素,我们研究了在省医院接受产前门诊单纯妊娠≥32周的健康女性。在1996年6月至1999年3月之间,对5093名孕妇进行了疟疾和人类免疫缺陷病毒(HIV)感染检查:20.1%的妇女为寄生虫病,24.9%的妇女为HIV血清阳性。 2502名妇女在医院分娩并获得了涂片:胎盘疟疾,孕产妇外周寄生物血症和HIV感染率分别为19.0%,15.2%和24.5%。 HIV感染(风险比[RR] 1.58,95%置信区间[95%CI] 1.32-1.89),年轻年龄(<21岁:RR 1.51,95%CI 1.19-1.91),是初生动物(RR 1.41、95) %CI 1.05-1.88),城郊居民(RR 1.50,95%CI 1.21-1.88)和Luo种族(RR 1.74,95%CI 1.35-2.24)是分娩时疟疾的危险因素。据报道,有2.1%的妇女使用磺胺多辛-乙胺嘧啶(SP)是一种保护因素(RR 0.44,95%CI 0.18-1.06)。在孕晚期结果相似。在这种城市/郊区环境中,预防艾滋病毒感染,将第一次怀孕推迟到青春期之后,并应用有效的抗疟疾策略,例如使用SP进行间歇性治疗,将减少怀孕期间疟疾的流行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号